Showing results (171-180 of 658) with videos related to
Sort By:
Pageof 66
BMC Health Services Research|April 12, 2022
Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory studyAbdullah Alibrahim, Jeanne C Marsh, Hortensia Amaro, et al.Urological Research|January 1, 1987
Carbohydrate residues in non-malignant prostatic epithelium as revealed by lectinsP D Abel, A Leathem, A Aylott, et al.Scientific Reports|May 14, 2026
The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorderAlannah McEvoy, Myanca Rodrigues, Jacqueline Hudson, et al.American Journal of Hospital Pharmacy|June 1, 1979
Pharmacist monitoring of parenteral nutrition: clinical and cost effectivenessK D Mutchie, K A Smith, M W MacKay, et al.Journal of Substance Abuse Treatment|April 27, 2010
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006Bohdan Nosyk, David C Marsh, Huiying Sun, et al.Bone Marrow Transplantation|February 1, 1997
Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemiaS B Killick, J C Marsh, J C Booth, et al.The International Journal on Drug Policy|September 6, 2024
Expert providers implement integrated and coordinated care in opioid use disorder treatmentLesley M Harris, Erick G Guerrero, Tenie Khachikian, et al.International Journal of Pharmaceutics|November 24, 1999
Pulmonary delivery of a dopamine D-1 agonist, ABT-431, in dogs and humansY Zheng, K C Marsh, R J Bertz, et al.The Journal of Pathology|January 12, 2000
aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8T J Dorkin, M C Robinson, C Marsh, et al.British Journal of Haematology|June 1, 1991
In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemiaJ C Marsh, J Chang, N G Testa, et al.Pageof 66